Navigation Links
China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk

DUBLIN, Aug. 28, 2015 /PRNewswire/ --

Research and Markets ( has announced the addition of the "Investigation Report on China's Insulin Aspart Market, 2010-2019" report to their offering.

Developed by Novo Nordisk, insulin aspart (under the trade name of Novolog) is an important drug for the treatment of diabetes. Compared with human insulin, insulin aspart, as a fast- acting insulin analog, starts working fast and reports higher peak of glucose- lowering action and lower risk of hypoglycemia. Ever since insulin aspart for injection was approved to enter China in 2012, it has been in the market for over a decade. Although the market is currently dominated by product of Novo Nordisk, some local enterprises are trying to make generic drugs. China Food and Drug Administration (CFDA) announced on its website on Jun.3, 2014 that Hisun's application to produce the APIs of insulin aspart and insulin aspart for injection through recombinant DNA technology has been accepted.

Insulin aspart developed fast after entering China. Its sales value reached CNY 336 million in 2013 and CNY 380 million in 2014 with a year-on-year increase of 13.10% while its sales volume reached 4.42 million in 2013 and 5.01 million in 2014, increasing 13.35% year on year. With economic development and lifestyle changes, the incidence of diabetes in China will keep going up, which fosters the huge demand for insulin aspart. Currently, the market is dominated by Novo Nordisk (Denmark) and Novo Nordisk (China), the former enjoying a larger market share of 100% with sales value reaching nearly CNY 380 million in 2014. As some local enterprises are trying to make generic drugs of insulin aspart, the monopoly of Novo Nordisk is expected to be broken by local products in the next few years.

Key Topics Covered:

1 Related Concepts of Insulin Aspart

2 Market Profile of Insulin Aspart in China

3 Survey on Insulin Aspart Sales in China, 2010-2014

4 Survey on Market Share of Major Manufacturers of Insulin Aspart in China, 2010-2014

5 Survey on Dosage Forms of Insulin Aspart in China, 2010-2014

6 Reference Price of Insulin Aspart in Chinese Hospitals in 2014

7 Major Manufacturers of Insulin Aspart in Chinese Market, 2010-2014

8 Market Outlook of Insulin Aspart in China, 2015-2019

Companies Mentioned

- Novo Nordisk

For more information visit

Media Contact: Laura Wood , +353-1-481-1716,

SOURCE Research and Markets
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. RuiYi and Genor BioPharma Collaborate on Development in China of RYI-008, a Novel Therapeutic for Autoimmune Diseases and Cancer
2. Hemp, Inc. Signs Letter of Intent with One of Chinas Largest Agricultural Producers, Yasheng Group
3. China Pharmaceutical Market Guidebook Series (4) 2013 Report
4. Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines
5. China Biologic Comments on the Proposed Shanghai RAAS Transaction
6. China Nepstar Chain Drugstore Ltd. Announces Appointment of New Director
7. China Nepstar Chain Drugstore Ltd. Reports First Quarter 2013 Financial Results
8. iBio Obtains New IP Protection in China
9. China & North East Asia Medical Device Market Reports
10. China Biologic Updates the Hong Kong Litigation in respect of the Shares Held by Ms. Siu Ling Chan
11. OrthoTec China 2013 is Coming Up Soon
Post Your Comments:
(Date:2/13/2020)... MATEO, Calif. (PRWEB) , ... February 13, 2020 , ... ... their finances show that they are maintaining a generally positive outlook on the ... contradictory indicators. , Asked if they are better off today than a year ago, ...
(Date:2/11/2020)... Calif. (PRWEB) , ... February 11, 2020 , ... ... in first aid and other safety measures, is offering courses for hospital and ... training is a requirement for medical practitioners like nurses, doctors, and other staff ...
(Date:2/11/2020)... , ... February 11, 2020 , ... Acuity Eye ... Eye Center run by Dr. Daniel Coden, Dr. Arthur Perry, and Dr. Steven Pratt ... have served patients in the La Jolla and San Diego community for over 40 ...
Breaking Medicine Technology:
(Date:2/13/2020)... ... 13, 2020 , ... Charles Seal-Villafranca, DHA(c), MSHA, CDP, ALFM-BC, ... announced today his re-election as the President of the Arizona State Board of ... , As President of the State Board, Villafranca acts as the chief judge ...
(Date:2/11/2020)... ... 11, 2020 , ... There are many reasons why Care to Care is ... truly raises us above our competitors is our true Peer to Peer process. At ... years of clinical experience. We understand that it is impossible to create criteria to ...
(Date:2/11/2020)... ... 2020 , ... This week marks the launch of ... Mindful Meat Eating for the Modern Omnivore . Authored by nationally-recognized butcher and ... brings discussions of responsible meat production, consumption, and economics into the year 2020, ...
(Date:2/10/2020)... ... February 10, 2020 , ... C. A. Shively officially ... At the time he was still in the music business as a majority label ... to create marketing campaigns for HNF, and HNF to create any music compositions needed ...
(Date:2/10/2020)... ... February 10, 2020 , ... ... a medical device company dedicated to assisting healthcare professionals (HCPs) to improve ... the launch of the Solesta® Reimbursement Assistance Program. , Solesta is ...
Breaking Medicine News(10 mins):